- Direk Limmathurotsakul, Head of Microbiology at Mahidol-Oxford Tropical Medicine Research Unit (MORU), Mahidol University (Thailand)
- Souha S. Kanj, Professor of Medicine, Head of Division of Infectious Diseases, Chair of Infection Control Program, American University of Beirut Medical Center (Lebanon)
- Sujith J. Chandy, Director, ReAct Asia Pacific, Professor of Clinical Pharmacology, Christian Medical College, Vellore (India)
Moderator: Philip Howard, Professor at University of Leeds, Consultant Antimicrobial Pharmacist at Leeds Teaching Hospitals NHS Trust and Vice President of British Society of Antimicrobial Chemotherapy (UK)
Inappropriate antibiotic use is a problem around the world and lack of stewardship of these life -saving drugs is a major driver of antibiotic resistance. However, the lack of access to antibiotics causes eight times more deaths every year than the estimates for antibiotic resistance (5.7 million deaths versus 700,000). Most new antibiotics are only available in less than 10 countries and rarely for children and babies for up to a decade after adult use is approved. Lack of good stewardship coupled with lack of access to old and new drugs can be especially problematic for some LMICs – where the burden of drug-resistant infections can be high.
In this webinar, the panellists discussed the delicate balance between access and stewardship and shared their experiences from working in infectious diseases and antimicrobial resistance in India, Lebanon and Thailand.
This live webinar including interactive Q&A session was broadcast on 1 July 2021.
If you have questions or comments, please let us know: email@example.com.